Showing results (21-30 of 61) with videos related to
Sort By:
Pageof 7
Oral Radiology|January 20, 2021
Can MRI-derived depth of invasion predict nodal recurrence in oral tongue cancer?Anri Minamitake, Ryuji Murakami, Fumi Sakamoto, et al.Neuropathology : Official Journal of the Japanese Society of Neuropathology|November 9, 2022
Macroglossia in rapidly progressive inclusion body myositisYoshimune Yamasaki, Akihiro Mukaino, Satoshi Yamashita, et al.Scientific Reports|March 18, 2021
Colonization of distant organs by tumor cells generating circulating homotypic clusters adaptive to fluid shear stressManabu Maeshiro, Satoru Shinriki, Rin Liu, et al.IJU Case Reports|March 6, 2023
Sicca syndrome during ipilimumab and nivolumab therapy for metastatic renal cell carcinomaTakuya Segawa, Takanobu Motoshima, Junji Yatsuda, et al.Cell Reports|April 9, 2020
FTO Demethylates Cyclin D1 mRNA and Controls Cell-Cycle ProgressionMayumi Hirayama, Fan-Yan Wei, Takeshi Chujo, et al.Molecular and Clinical Oncology|June 8, 2017
Salivary duct carcinoma treated with cetuximab-based targeted therapy: A case reportKenta Kawahara, Akimitsu Hiraki, Ryoji Yoshida, et al.Radiation Oncology (London, England)|May 29, 2020
Hypofractionated palliative volumetric modulated arc radiotherapy with the Radiation Oncology Study Group 8502 "QUAD shot" regimen for incurable head and neck cancerRyo Toya, Tetsuo Saito, Kohsei Yamaguchi, et al.International Journal of Clinical Oncology|July 11, 2025
Pterygomandibular raphe invasion as a novel grading and prognostic factor for squamous cell carcinoma of buccal mucosa: a retrospective study with propensity score matchingRyoji Yoshida, Riu Lin, Keisuke Yamana, et al.International Journal of Molecular Sciences|October 23, 2019
Loss of Tumor Suppressor CYLD Expression Triggers Cisplatin Resistance in Oral Squamous Cell CarcinomaNaoki Suenaga, Mimi Kuramitsu, Kanae Komure, et al.Journal of Radiation Research|April 10, 2012
Histopathological changes in parotid and submandibular glands of patients treated with preoperative chemoradiation therapy for oral cancerKeiko Teshima, Ryuji Murakami, Ryoji Yoshida, et al.Pageof 7